PDCD1 and lung carcinoma: Recently, immune checkpoint inhibitors (ICIs) are aimed at cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death protein ligand 1 (PD-L1) has brought great hope for the treatment of lung carcinoma.